The Department of Comparative Cultural Studies at the University ofHouston is seeking a part-time Lecturer in its Religious StudiesProgram. Candidates should be able to contribute to more than oneof the following areas of expertise or specialization:Teaching of a broad introductory course into ReligiousStudies.The study of the religions and cultures of the Indian Subcontinentwith a focus on transnational and Indian diasporic identities. Theideal candidate’s work and publications might focus on historicaland literary aspects and create awareness of the variety ofidentities of the Indian Subcontinent in local and globalframeworks.The study of the spiritualties, history, and cultures of theIndigenous Peoples of North America, with a preference of SouthernIndigenous Peoples. The ideal candidate’s work and publicationsmight focus on historical and literary aspects of the diverseexperience of Indigenous Peoples while demonstrating the continuedrelevance of their spirituality and wisdom.The study of the New Testament. The ideal candidate should be ableto teach a broad introduction to the early Christian literaturewith a focus on its relevance for the modern western culture.The study of feminism / womanism in the area of religion. The idealcandidate’s work and publications might focus on historical andliterary aspects and create awareness of the variety of feminist /womanist expressions.We encourage applicants to demonstrate how their teaching andresearch will strengthen the interdisciplinary objectives of ourDepartment of Comparative Cultural Studies. The department combinesdegree programs in Religious Studies, Anthropology, and LiberalStudies. The position will be in the Religious Studies Program withthe expectation that the candidate will also display interest inAnthropology and Liberal Studies.The University of Houston is an Equal Opportunity/AffirmativeAction institution. Minorities, women, veterans and persons withdisabilities are encouraged to apply.Qualifications :Masters degree in Religious Studies or related discipline required.Candidates with a Ph.D. preferred.Notes to Applicant: Please submit a list with the names ofthree references electronically as one single PDF file to: Dr.Christian A. Eberhart, Director, Religious Studies [email protected] Official transcripts are required for a facultyappointment and will be requested upon selection of the finalcandidate. All positions at the University of Houston are securitysensitive and will require a criminal history check.
Topics : Takeda Pharmaceutical Co Ltd could start a clinical trial as early as July for a potential treatment of COVID-19 that is based on antibodies from recovered patients’ blood, company executives said on Wednesday.The clinical trial would include hundreds of patients and take several months to complete. If successful, Japan’s Takeda could file for approval by US authorities this year, said Julie Kim, president of the plasma-derived therapies unit of Takeda.”When the product will be available beyond the clinical study is still a bit unclear,” Kim said on an investor call. “But we do expect that before the end of the year, we should see some information in terms of broader use.” “It is a scarce resource,” Kim said. “Antibodies don’t last forever and we have to capture people within that time window. This is dependent on the progression of COVID-19 within different geographies.”Takeda said last week it has joined with nine other companies that work on blood plasma-based therapies to develop a treatment for COVID-19 patients. The CoVIg-19 Plasma Alliance also includes Biotest AG, CSL Behring, and Octapharma Plasma, among others.Takeda is working with the US National Institute of Health (NIH) on a clinical trial that would give all the companies in its partnership the ability to produce the treatment, which will not have standard drug industry patent protections because it uses existing technology. Fighting disease with blood from survivors is an ancient strategy that has not been well tested for the novel coronavirus, which emerged in China late last year and has spread around the world. Some hospitals are already collecting blood plasma from recovered patients and infusing it into people who are sick with the coronavirus, but its efficacy is still being studied.The new coronavirus has infected 4.3 million people worldwide and nearly 300,000 have died, according to a Reuters tally. The pandemic has spurred several drugmakers to race to develop a viable treatment or vaccine.Takeda’s proposed treatment offers a standardized dose of antibodies. It also has a much longer shelf life than unprocessed blood plasma and doesn’t need to be limited to patients with matching blood types. There are not yet any treatments for COVID-19, the disease caused by the coronavirus, which have been approved by the US Food and Drug Administration. However, some such as Gilead Sciences Inc’s antiviral drug remdesivir have received emergency authorization from the regulator.The number of patients who could be aided by Takeda’s treatment, initially called TAK-888, depends in part on the availability of blood donations, Kim said in an interview with Reuters.
Danny Lauer led all 50 laps in winning the IMCA Modified feature at Merced Speedway’s April 14 Bill Egleston Tribute. The $4,015 checkers put Lauer on the ballot for the Fast Shafts All-Star Invitational. (Photo by Katherine Householder, Totally In The Zone Photography)MERCED, Calif. (April 14) – It had been a few years since Danny Lauer turned laps at Merced Speedway but it didn’t take him long to find the fastest way the oval at Saturday’s Bill Egleston Tribute.Lauer led all 50 laps of the evening’s IMCA Modified feature, earning $4,015 along with a spot on the Fast Shafts All-Star Invitational ballot.“We were stoked. We unloaded the car and never touched a thing. It was fast all night,” Lauer said after pocketing the biggest check of his career in the class. “I took the lead going into (turn) one on the first lap and ran the bottom. I figured if anyone was going to pass they’d have to go around me.”The last yellow came out with nine circuits left. Lauer kept Austin Burke at bay to win for the first time this season and the first time he’s entered a 50-lapper that didn’t have a pit stop at midway.“We haven’t won that many races the last few years. The sport evolved and we didn’t keep up with it the way we should have,” said Lauer, who had crossed racing paths with fellow Modified driver Egleston at weekly events in California and en route to last November’s Duel In The Desert.“We got this Rage before the Wild West Tour in Oregon last year and have been getting it dialed in,” he continued. “The $4,015 was awesome but I want to be more consistent. I think I have the car now and want to prove it.”Darrell Hughes, Roger Holder and Shane DeVolder were next across the stripe. Modified entries came from across California and Arizona, Nevada and Oregon as well.A regular at Merced during 2013 and 2014 California State championship campaigns, Nick Spainhoward returned to his old stomping grounds to lead all 25 laps of the Karl Chevrolet Northern SportMod main event.His $1,815 payday was also a career best.“I tried to stay smooth and steady on the bottom. I heard Garrett (Jernagan) a couple times,” said Spainhoward. “There are a ton of fast guys on the West Coast and it seemed like all of them were on my back bumper.”Jernagan, Tim Elias, Fred Ryland and Chris Falkenberg rounded out the top five. Spainhoward got into a lapped car while running with traffic just before midway but righted the ship and stayed in front the rest of the way.“I met Bill at Chowchilla in 2012 back when nobody knew who I was,” Spainhoward said after career win number 47 in the class. “He always came over and talked to me. Bill was a good guy. It was important for me to be here and I was happy to have been part of this event.”Feature ResultsModifieds – 1. Danny Lauer; 2. Austin Burke; 3. Darrell Hughes; 4. Roger Holder; 5. Shane DeVolder; 6. Troy Foulger; 7. Cody Burke; 8. Paul Stone; 9. Bobby Hogge IV; 10. Ryan Porter; 11. Nick Trenchard; 12. Brian Pearce; 13. Jeff Streeter; 14. Chris Lewis; 15. Tim Balding; 16 Chett Reeves; 17. Carl Berendsen; 18. Chris Crompe; 19. Stephen Hopf; 20. Brian Lewis; 21. Randy Brown; 22. Robby Sawyer; 23. Freddie Plourde; 24. Bret Bennett.Northern SportMods – 1. Nick Spainhoward; 2. Garrett Jernagan; 3. Tim Elias; 4. Fred Ryland; 5. Chris Falkenberg; 6. Danny Roe; 7. Bruce Nelson; 8. Matthew Mayo; 9. Andrew Peckham; 10. Jeremy Hoff; 11. Austin Manzella; 12. Kelly Wilkinson; 13. Chase Thomas; Atwater; 14. K.C. Keller; 15. Patti Ryland; 16. Anthony Giuliani; 17. T.J. Etchinson III; 18. Jack Aguiar; 19. Dale Grissom; 20. Chuck Weir; 21. Cody Parker; 22. Andrew Odgers; 23. Tanner Thomas; 24. Kevin Johnson.